Access cutting-edge myeloid cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access myeloid cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myeloid cancer treatment provided free
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the course of their myeloid cancer (acute myeloid leukemia or myelodysplastic syndrome) treatment. This study involves testing patients' bone marrow and blood for certain biomarkers. A biomarker (sometimes called a marker) is any molecule in the body that can be measured. Doctors look
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this myeloid cancer clinical trial in Phoenix, AZ
If you're searching for myeloid cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myeloid cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.